The next board meeting for Capricor Therapeutics Inc is on 19 Mar 2026 for the purpose of Capricor Therapeutics Inc Fourth Quarter Earnings Results for 2025See details
Capricor Therapeutics Inc has a share price target of US$ 54, revenue growth forecast of -97.4%, and profit growth estimate of -146.9% for FY25, based on top 10 analyst calls.